Nomura Holdings Inc Johnson & Johnson Call Options Transaction History

Nomura Holdings Inc

$41.1 Billion
Q3 2024

Call Options

14 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q3 2024 Nov 14, 2024	SELL	$145.48 - $167.38 $494,631 - $569,092	-3,400 Reduced 2.24%	148,600 $24.1 Million
Q2 2024 Aug 14, 2024	BUY	$144.38 - $157.78 $21.9 Million - $24 Million	152,000 New	152,000 $22.2 Million
Q4 2023 Feb 14, 2024	BUY	$145.6 - $158.88 $1.02 Million - $1.11 Million	7,000 New	7,000 $1.1 Million
Q1 2023 May 15, 2023	SELL	$151.05 - $180.26 $19.1 Million - $22.8 Million	-126,300 Reduced 88.69%	16,100 $2.5 Million
Q4 2022 Feb 14, 2023	SELL	$160.2 - $179.79 $2.9 Million - $3.25 Million	-18,100 Reduced 11.28%	142,400 $24.9 Million
Q3 2022 Nov 15, 2022	BUY	$161.33 - $179.52 $1.26 Million - $1.4 Million	7,800 Added 5.11%	160,500 $26.4 Million
Q2 2022 Aug 15, 2022	BUY	$168.19 - $186.01 $25.2 Million - $27.9 Million	150,000 Added 5555.56%	152,700 $27 Million
Q4 2021 Feb 14, 2022	SELL	$155.93 - $173.01 $33.4 Million - $37 Million	-213,900 Reduced 98.75%	2,700 $458,000
Q4 2020 Feb 16, 2021	BUY	$137.11 - $157.38 $29.7 Million - $34.1 Million	216,600 New	216,600 $33.7 Million
Q1 2020 May 14, 2020	SELL	$111.14 - $153.99 $43.2 Million - $59.9 Million	-388,700 Closed	0 $0
Q4 2019 Feb 14, 2020	BUY	$127.5 - $146.44 $24.3 Million - $27.9 Million	190,300 Added 95.92%	388,700 $55.7 Million
Q3 2018 Nov 14, 2018	BUY	$121.58 - $142.88 $19.9 Million - $23.4 Million	164,000 Added 476.74%	198,400 $27.8 Million
Q2 2018 Aug 14, 2018	SELL	$119.4 - $131.76 $26.6 Million - $29.3 Million	-222,600 Reduced 86.61%	34,400 $3.19 Million
Q4 2017 Feb 14, 2018	BUY	$131.22 - $143.62 $33.7 Million - $36.9 Million	257,000	257,000 $35.7 Million

Others Institutions Holding JNJ

# of Institutions

4,271

Shares Held

1.68B

Call Options Held

17.6M

Put Options Held

14.5M

View Full List

About JOHNSON & JOHNSON

Ticker JNJ
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,614,479,872
Market Cap $406B
Description
Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide. The company's Consumer Health segment offers baby care products under the JOHNSON'S and AVEENO Baby brands; oral care products under the LISTERINE brand; skin health/beauty products under the...

More about JNJ

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Nomura Holdings Inc, based on Form 13F filings with the SEC.

News

Stay updated on Nomura Holdings Inc with notifications on news.

Account